1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7078)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22470)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10530)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (298)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer prevalence of MET fusions and clinical response to MET- targeted therapy
    Meeting Abstract

    Vojnic, M.; Odintsov, I.; Liu, Z.; Lu, D.; Harshan, M.; Ameri, A.; Machnicki, S.; Xiao, X.; Lockwood, W.; Ladanyi, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • A first-in-human phase I trial of NB003, a potent and selective KIT/PDGFRa inhibitor, in patients with advanced gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Chi, P.; Shen, L.; Li, J.; Zhang, J.; Hu, K.; Zhang, L.; Xu, Y.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Detection of alternative lengthening of telomeres (ALT) across cancer types based on tumor-normal multigene panel sequencing
    Meeting Abstract

    Heredia, J. B.; Diplas, B. H.; El Nahhas, O. S. M.; Selenica, P.; Pareja, F.; Mandelker, D.; Weigelt, B.; Riaz, N.; Rosen, E.; Sfeir, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Combined patient specific tumor and HPV sequencing enables high sensitivity detection of ctDNA in HPV-associated oropharyngeal carcinoma patients
    Meeting Abstract

    Diplas, B. H.; Brown, D.; Pei, X.; Graybill, C.; Novaj, A.; Korn, W. M.; Daber, R.; Humm, J.; Shukla-Dave, A.; Schoder, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma
    Meeting Abstract

    Blumenthal, D.; Mellinghoff, I. K.; van den Bent, M. J.; Touat, M.; Peters, K.; Clarke, J.; Mendez, J.; Welsh, L.; Mason, W.; Hottinger, A. F.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Prognostic and predictive impact of estrogen/progesterone receptor (ER/PR), and Ki-67 expression: An exploratory analysis from the monarchE trial in patients with high-risk, HR+, HER2-, early breast cancer (EBC)
    Meeting Abstract

    Goetz, M. P.; Turner, N.; Sasano, H.; Arteaga, C.; Chandarlapaty, S.; Loi, S.; Reis-Filho, J. S.; Kreipe, H.; Harbeck, N.; Fasching, P.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Regression-based deep-learning predicts breast cancer recurrence risk score from pathology slides
    Meeting Abstract

    El Nahhas, O. S. M.; Loeffler, C. M. L.; Marra, A.; Carrero, Z.; Pareja, F.; Wen, H.; Weigelt, B.; Selenica, P.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Evasion to CD47-targeted phagocytosis in DLBCL
    Meeting Abstract

    Fernandez-Pacheo, F.; Busik, J.; Man, J.; Kolesnick, R.; Wendel, H. G.
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Proton reirradiation for high-risk recurrent or new primary breast cancer
    Review

    Chakraborty, M. A.; Khan, A. J.; Cahlon, O.; Xu, A. J.; Braunstein, L. Z.; Powell, S. N.; Choi, J. I.
    Cancers (2023)

    Fulltext@MSK | Save